Predictors of response to serotonin reuptake inhibitors in obsessive-compulsive disorder.
40-60% of patients with obsessive compulsive disorder (OCD) do not respond adequately to serotonin reuptake inhibitors (SRIs). It is important to identify predictors of response to help individualize treatment and identify refractory patients early in the course of treatment.



We review the current literature on predictors of response to SRIs in adult patients with OCD including clinical features, neuropsychological profile, neuroimaging, genetics and other biological factors. We conducted a literature search in PUBMED database using the MeSH terms 'Obsessive-Compulsive Disorder', 'drug therapy', 'treatment outcome', 'neuroimaging', 'genetics' 'cytokines' and obtained 60 articles. Expert commentary: Poor-insight into obsessions, symmetry/hoarding and contamination/washing dimension and the presence of certain personality disorders are associated with poor response to SRIs. Orbitofrontal cortex, anterior cingulate cortex, caudate, putamen and thalamus volume changes in structural imaging studies and altered activity in the same regions in functional imaging studies were found predictive of poor response. However, there is inconsistency with regards to direction of change. Genes involving serotonergic and glutamatergic signalling pathways have emerged as predictors in recent studies. Studies with large sample size, standardised methodology and rigorous statistical analyses are required before predictors can be utilised in routine clinical practice.
a Department of Psychiatry , National Institute of Mental Health and Neurosciences (NIMHANS) - OCD Clinic , Bangalore , India.
Nandita
N
Hazari
a Department of Psychiatry , National Institute of Mental Health and Neurosciences (NIMHANS) - OCD Clinic , Bangalore , India.
Janardhanan C
JC
Narayanaswamy
a Department of Psychiatry , National Institute of Mental Health and Neurosciences (NIMHANS) - OCD Clinic , Bangalore , India.
Shyam Sundar
SS
Arumugham
D001931:Brain Mapping / Q000379:methods; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D011237:Predictive Value of Tests; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D017367:Selective Serotonin Reuptake Inhibitors
Obsessive compulsive disorder; biomarker; pharmacological; serotonin reuptake inhibitors; treatment outcome